These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23067577)
1. Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride. Belujon P; Patton MH; Grace AA Int J Neuropsychopharmacol; 2013 Apr; 16(3):507-12. PubMed ID: 23067577 [TBL] [Abstract][Full Text] [Related]
2. Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia. Belujon P; Patton MH; Grace AA Cereb Cortex; 2014 Apr; 24(4):968-77. PubMed ID: 23236209 [TBL] [Abstract][Full Text] [Related]
3. Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction. Esmaeili B; Grace AA Neuropsychopharmacology; 2013 Sep; 38(10):1871-80. PubMed ID: 23471079 [TBL] [Abstract][Full Text] [Related]
4. Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow. Belujon P; Grace AA J Neurosci; 2008 Sep; 28(39):9797-805. PubMed ID: 18815264 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia. Bilecki W; Wawrzczak-Bargieła A; Majcher-Maślanka I; Chmelova M; Maćkowiak M Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445411 [TBL] [Abstract][Full Text] [Related]
6. Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia. Goda SA; Olszewski M; Piasecka J; Rejniak K; Whittington MA; Kasicki S; Hunt MJ Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():44-51. PubMed ID: 25862088 [TBL] [Abstract][Full Text] [Related]
7. Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice. Takahashi K; Nakagawasai O; Sakuma W; Nemoto W; Odaira T; Lin JR; Onogi H; Srivastava LK; Tan-No K Neuropharmacology; 2019 May; 150():1-14. PubMed ID: 30831160 [TBL] [Abstract][Full Text] [Related]
8. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia. Gill KM; Cook JM; Poe MM; Grace AA Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874 [TBL] [Abstract][Full Text] [Related]
9. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment. Stark T; Di Bartolomeo M; Di Marco R; Drazanova E; Platania CBM; Iannotti FA; Ruda-Kucerova J; D'Addario C; Kratka L; Pekarik V; Piscitelli F; Babinska Z; Fedotova J; Giurdanella G; Salomone S; Sulcova A; Bucolo C; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V Biochem Pharmacol; 2020 Jul; 177():114004. PubMed ID: 32360362 [TBL] [Abstract][Full Text] [Related]
10. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437 [TBL] [Abstract][Full Text] [Related]
11. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function. Chalkiadaki K; Velli A; Kyriazidis E; Stavroulaki V; Vouvoutsis V; Chatzaki E; Aivaliotis M; Sidiropoulou K Neuropharmacology; 2019 Jan; 144():193-207. PubMed ID: 30366002 [TBL] [Abstract][Full Text] [Related]
12. Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Léna I; Chessel A; Le Pen G; Krebs MO; Garcia R Psychopharmacology (Berl); 2007 Jun; 192(3):373-83. PubMed ID: 17279373 [TBL] [Abstract][Full Text] [Related]
13. Modulation of hippocampus-prefrontal cortex synaptic transmission and disruption of executive cognitive functions by MK-801. Blot K; Kimura S; Bai J; Kemp A; Manahan-Vaughan D; Giros B; Tzavara E; Otani S Cereb Cortex; 2015 May; 25(5):1348-61. PubMed ID: 24304584 [TBL] [Abstract][Full Text] [Related]
14. Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride. Pezze MA; Dalley JW; Robbins TW Psychopharmacology (Berl); 2009 Jan; 202(1-3):307-13. PubMed ID: 18985321 [TBL] [Abstract][Full Text] [Related]
15. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult. O'Reilly KC; Perica MI; Fenton AA Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950 [TBL] [Abstract][Full Text] [Related]
16. Essential role of D1 but not D2 receptors in methamphetamine-induced impairment of long-term potentiation in hippocampal-prefrontal cortex pathway. Ishikawa A; Kadota T; Kadota K; Matsumura H; Nakamura S Eur J Neurosci; 2005 Oct; 22(7):1713-9. PubMed ID: 16197511 [TBL] [Abstract][Full Text] [Related]
17. Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophrenia. Albeely AM; Williams OOF; Blight CR; Thériault RK; Perreault ML Schizophr Res; 2024 May; 267():451-461. PubMed ID: 38643726 [TBL] [Abstract][Full Text] [Related]
19. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia. Jodo E J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022 [TBL] [Abstract][Full Text] [Related]
20. A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research. Du Y; Li XS; Chen L; Chen GY; Cheng Y Schizophr Bull; 2020 Apr; 46(3):612-622. PubMed ID: 31738422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]